British American Tobacco (BTI) is positioned for resilience with a diversified portfolio spanning premium, value, and discount tobacco products, alongside high-growth vapor and oral nicotine offerings. The company expects to expand its US nicotine market share in the second half of 2026 with new launches like Velo's stronger and limited-edition flavors and Vuse Pro's fruit-flavored pods. Despite recent stock price declines, BTI now offers a discounted price-to-earnings ratio of 11.13x and an attractive forward dividend yield of 6.28%, signaling strong upside potential. Risks include increased competition in the vapor/oral nicotine segment, potential delays in US FDA approvals, and seasonal sales softness through October. Overall, BTI is rated a Buy due to its resilient tobacco portfolio and promising dual growth and income prospects.
British American Tobacco's focus on diversifying its nicotine products and expanding US market share comes as its shares trade at USD 52.64 on Pluang, down 1.03% as of Oct 03, 2026 22:11 WIB. The stock offers a dividend yield of 6.34%, slightly above the article's figure, and investors on Pluang show full buying interest with 100% buy orders. Its market capitalization stands at $112.45 billion, reflecting its significant presence in the consumer staples sector.
